https://www.selleckchem.com/products/lcl161.html
This study evaluated the use of the Medtronic MiniMed 670G system in adults with type 1 diabetes mellitus from a large endocrinology practice and its impact on glycemic control, quality of life (QoL), compliance and safety. 84 participants completed one site visit for data collection. Percentage of time in range (TIR 70-180mg/dL), hyperglycemia or time above range (TA (180mg/dL), hypoglycemia or time below range (TBR) (70mg/dL), HbA1c, average blood glucose (ABG), and other metrics were evaluated at the last visit using the sys
Like
Comment
Share
